Your browser doesn't support javascript.
Immunological considerations for COVID-19 vaccine strategies.
Jeyanathan, Mangalakumari; Afkhami, Sam; Smaill, Fiona; Miller, Matthew S; Lichty, Brian D; Xing, Zhou.
  • Jeyanathan M; McMaster Immunology Research Centre, McMaster University, Hamilton, ON, Canada.
  • Afkhami S; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
  • Smaill F; Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON, Canada.
  • Miller MS; McMaster Immunology Research Centre, McMaster University, Hamilton, ON, Canada.
  • Lichty BD; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
  • Xing Z; Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON, Canada.
Nat Rev Immunol ; 20(10): 615-632, 2020 10.
Article in English | MEDLINE | ID: covidwho-744378
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to humanity in a century. It is widely believed that prepandemic normalcy will never return until a safe and effective vaccine strategy becomes available and a global vaccination programme is implemented successfully. Here, we discuss the immunological principles that need to be taken into consideration in the development of COVID-19 vaccine strategies. On the basis of these principles, we examine the current COVID-19 vaccine candidates, their strengths and potential shortfalls, and make inferences about their chances of success. Finally, we discuss the scientific and practical challenges that will be faced in the process of developing a successful vaccine and the ways in which COVID-19 vaccine strategies may evolve over the next few years.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Severe Acute Respiratory Syndrome / Pandemics / Betacoronavirus / Antibodies, Viral Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Nat Rev Immunol Journal subject: Allergy and Immunology Year: 2020 Document Type: Article Affiliation country: S41577-020-00434-6

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Severe Acute Respiratory Syndrome / Pandemics / Betacoronavirus / Antibodies, Viral Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Nat Rev Immunol Journal subject: Allergy and Immunology Year: 2020 Document Type: Article Affiliation country: S41577-020-00434-6